Dr. Rahhal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Retina Vitreous Associates Medical Group
9001 Wilshire Blvd, Ste 301
Beverly Hills, CA 90211Phone+1 310-854-6201
Education & Training
- University of California (San Diego) Medical CenterFellowship, Surgical Retina and Vitreous, 1994 - 1996
- New York Presbyterian Hospital (Cornell Campus)Residency, Ophthalmology, 1991 - 1994
- Olive View/UCLA Medical CenterInternship, Internal Medicine, 1990 - 1991
- Uconn School Of MedicineClass of 1990
- University of PennsylvaniaBA, Biochemistry, 1982 - 1986
Certifications & Licensure
- CA State Medical License 1994 - 2025
- NY State Medical License 1991 - 2001
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- The Retina Society
- American Society of Retina Specialists
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema Start of enrollment: 2013 Nov 01
- Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD Start of enrollment: 2016 Feb 16
- TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) Start of enrollment: 2017 Apr 01
Publications & Presentations
PubMed
- 5 citationsLong-term Follow-up of a Phase 1/2a Clinical Trial of a Stem Cell-Derived Bioengineered Retinal Pigment Epithelium Implant for Geographic Atrophy.Mark S Humayun, Dennis O Clegg, Margot S Dayan, Amir H Kashani, Firas M Rahhal
Ophthalmology. 2024-06-01 - Real-World Outcomes of the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema.Christine Morozova, Lucas L Humayun, Jonathan Kasper, Andy Morozov, Homayoun Tabandeh
Journal of Vitreoretinal Diseases. 2024-05-16 - 23 citationsSurvival of an HLA-mismatched, bioengineered RPE implant in dry age-related macular degeneration.Amir H Kashani, Jane S Lebkowski, David R Hinton, Danhong Zhu, Mohamed A Faynus
Stem Cell Reports. 2022-03-08
Press Mentions
- Virtual Clinical Day Recap: Outlook Therapeutics Joined by Drs. Mark Humayun and Firas Rahhal to Discuss Need for FDA-Approved Ophthalmic Bevacizumab and Status of ONS-5010May 27th, 2021
- Virtual KOL Roundtable Recap: Outlook Therapeutics and Firas Rahhal, MD, Discussed Wet AMD Treatment Landscape and ONS-5010/LYTENAVA™November 11th, 2020
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: